Echosens
Paris, France· Est. 2001
Echosens manufactures FibroScan®, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease.
Private Company
Total funding raised: $70M
About
Echosens manufactures FibroScan®, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease.
Diagnostics
Funding History
4Total raised:$70M
Series B$25MMar 15, 2021
Series B$25MFeb 15, 2020
Series A$10MJun 15, 2018
Series A$10MJun 15, 2018